Eligible nominees include individuals, teams of researchers, or research institutions and are nominated solely for the scientific merit of their work. Although preference is given to scientific breakthroughs with direct or obvious clinical applications, all major accomplishments in type 1 or type 2 research are considered by the Selection Jury. Employees of for-profit pharmaceutical or biotechnology companies are not eligible.
Nominations for the Prize are made by members of the Selection Jury and are therefore not open to application. However, Letters of Recommendation for nominations will be accepted to afford the community at large an opportunity to suggest Nominees for the Prize to the Selection Jury.
Letters of Recommendation for nominations are provided to the jurors for consideration. Jurors may review these Letters at their discretion. Any person writing a Letter of Recommendation for Nomination is requested not to make direct contact with Jurors for the purpose of soliciting a recommendation for nominations or selection. Letters must not exceed 1,000 words. Letters are confidential and only made available to members of the Selection Jury.
View key dates and deadlines for the open call for nominations.
Selection Jury members are appointed by Harold Hamm Diabetes Center representatives with priority given to individuals who have served in international capacities in the field of diabetes research such as editors of major diabetes journals or recent leaders of major diabetes-related organizations.
Jed Friedman, PhD, Selection Jury Chairperson
Jed Friedman, PhD, Selection Jury Chairperson
Steven E. Kahn, MB, ChB
Jeffrey Pessin, PhD
Maike Sander, MD
Randy Seeley, PhD
Clay Semenkovich, MD
The 2026 Diabetes Care Summit will be held on Friday, Sept. 11, in Oklahoma City. As the region’s ...
View Event Details
Join us for the 22nd Annual Diabetes Research Symposium on Friday, Nov. 14, at the Samis Education ...
View Event Details
The 23rd annual Harold Hamm Diabetes Center Research Symposium will facilitate communication and ...
View Event DetailsDiabetes is a critical health challenge in Oklahoma, with more than 14 percent of the state’s adult population diagnosed with the disease—surpassing ...
Spring 2026 Newsletter This Spring issue highlights: Director's Corner Groundbreaking of New Diabetes Research Space in BSEB, Connect+Cure Gala, and ...
More than 800 people attended the 2025 Connect+Cure Gala on Wednesday night, raising $4.7 million to support research and programs at the OU Health ...